Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1465-993X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease ; volume:20 ; number:1 ; day:5 ; month:4 ; year:2019 ; pages:1-10 ; date:12.2019
Respiratory research ; 20, Heft 1 (5.4.2019), 1-10, 12.2019

Creator: Ho, Te-Wei
Huang, Chun-Ta
Tsai, Yi-Ju
Lien, Angela Shin-Yu
Lai, Feipei
Yu, Chong-Jen

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12931-019-1035-9

URN: urn:nbn:de:101:1-2019042522400315917143

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:44 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Ho, Te-Wei
Huang, Chun-Ta
Tsai, Yi-Ju
Lien, Angela Shin-Yu
Lai, Feipei
Yu, Chong-Jen
SpringerLink (Online service)

Other Objects (12)

Metformin Mitigates Trimethyltin-Induced Cognition Impairment and Hippocampal Neurodegeneration

The effects of metformin in type 1 diabetes mellitus

Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy

Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway

Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study

Empagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-13

Dapagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A19-52

Saxagliptin/Metformin (Diabetes mellitus Typ 2) : Nutzenbewertung gemäß § 35a SGB V

Metformin : Evidenzbericht zur S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge

Learning mitigates genetic drift

Unexpected adverse event of insulin therapy in diabetes mellitus

Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies

Metformin Mitigates Trimethyltin-Induced Cognition Impairment and Hippocampal Neurodegeneration

The effects of metformin in type 1 diabetes mellitus

Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy

Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway

Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study

Empagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-13

Dapagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A19-52

Saxagliptin/Metformin (Diabetes mellitus Typ 2) : Nutzenbewertung gemäß § 35a SGB V

Metformin : Evidenzbericht zur S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge

Learning mitigates genetic drift

Unexpected adverse event of insulin therapy in diabetes mellitus

Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies

Metformin Mitigates Trimethyltin-Induced Cognition Impairment and Hippocampal Neurodegeneration

The effects of metformin in type 1 diabetes mellitus

Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy

Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway

Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study

Empagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-13

Dapagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A19-52

Saxagliptin/Metformin (Diabetes mellitus Typ 2) : Nutzenbewertung gemäß § 35a SGB V

Metformin : Evidenzbericht zur S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge

Learning mitigates genetic drift

Unexpected adverse event of insulin therapy in diabetes mellitus

Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Metformin Mitigates Trimethyltin-Induced Cognition Impairment and Hippocampal Neurodegeneration

The effects of metformin in type 1 diabetes mellitus

Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy

Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway

Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study

Empagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-13

Dapagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A19-52

Saxagliptin/Metformin (Diabetes mellitus Typ 2) : Nutzenbewertung gemäß § 35a SGB V

Metformin : Evidenzbericht zur S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge

Learning mitigates genetic drift

Unexpected adverse event of insulin therapy in diabetes mellitus

Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies

Metformin Mitigates Trimethyltin-Induced Cognition Impairment and Hippocampal Neurodegeneration

The effects of metformin in type 1 diabetes mellitus

Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy

Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway

Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study

Empagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-13

Dapagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A19-52

Saxagliptin/Metformin (Diabetes mellitus Typ 2) : Nutzenbewertung gemäß § 35a SGB V

Metformin : Evidenzbericht zur S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge

Learning mitigates genetic drift

Unexpected adverse event of insulin therapy in diabetes mellitus

Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies

Metformin Mitigates Trimethyltin-Induced Cognition Impairment and Hippocampal Neurodegeneration

The effects of metformin in type 1 diabetes mellitus

Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy

Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway

Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study

Empagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-13

Dapagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A19-52

Saxagliptin/Metformin (Diabetes mellitus Typ 2) : Nutzenbewertung gemäß § 35a SGB V

Metformin : Evidenzbericht zur S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge

Learning mitigates genetic drift

Unexpected adverse event of insulin therapy in diabetes mellitus

Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies

Related objects

Reset password